SAMAHA ELI purchased 11.7% of their position (999.80K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market purchase worth $7.80M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/9/2024ACC: 0001877589-24-000006
+999.80K
Net shares
Net buyer
$7.80M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
999.80K acquired
Non-Derivative Transactions1
COM
Indirect
Shares
+999.80K
Price / share
$7.80
Trade value
$7.80M
% of position
11.7%
8/7/2024
8.51M→9.51M
Total
Net shares
+999.80K
Net value
$7.80M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COM Indirect | 8/7/2024 | P · Purchase | +999.80K | $7.80 | $7.80M | 11.7% | 8.51M | 9.51M |
| Total | +999.80K | $7.80M | ||||||
Derivative Transactions0
No derivative transactions reported